Helicobacter Pylori Testing Market size to exceed $560mn by 2025

Helicobacter Pylori Testing Market size is set to exceed USD 560 million by 2025; according to a new research report by Global Market Insights, Inc.

Innovations and technological advancements in H. pylori infection testing results in greater consumer satisfaction that will accelerate market growth. H. pylori is found in 50-80% of patients suffering with gastric ulcers and in 90% of patients with duodenal ulcers. Hence, rising prevalence of these symptoms will fuel the business expansion. Moreover, growing demand for diagnostics at relatively lower prices will augment the industry growth in the forthcoming years.


Request Sample Buy NowInquiry Before Buying


Surge in adoption of non-invasive methods will remain a key growth driver

The upsurge in prevalence of H. pylori infection, rise in demand for early detection of disorders such as peptic ulcer, gastric cancer and innovation in diagnostic techniques will further fuel the business of H. pylori testing. The increase in availability of affordable non-invasive tests is expected to increase the diagnosis, that in turn will boost the market expansion in near future. However, competitive pricing pressure due to presence of highly major market players may hinder market growth.

Stool antigen test to attain new heights in non-invasive testing market

Advancement in non-invasive testing for H. Pylori infections has greatly contributed to development of stool antigen diagnosis kits. In the U.S., 20% of the population under 30 and 50% of the population over 60 are infected with H. pylori. H. pylori can lead to serious sub-clinical infections. As noted in the ACG 2017 guidelines, stool antigen testing provides accurate detection of active H. pylori infection before and after treatment. This will significantly contribute to market growth.

Browse key industry insights spread across 180 pages with 162 market data tables & 09 figures & charts from the report, “Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point Of Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, Romania, Russia, China, India, Australia, South Korea, Brazil, Mexico, Chile, Argentina, South Africa, Saudi Arabia, Nigeria, Turkey), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

Laboratory-based test to reflect a positive growth trajectory

The laboratory-based H. pylori test are high volume test. Invasive tests such as histology, rapid urea test, culture etc. are majorly performed in laboratories as these tests requires biopsies. The segmental growth can be attributed to the availability of laboratories, presence of skilled lab professionals and well-developed infrastructure will augment business growth in upcoming years.

Diagnostic laboratories continue to dominate the overall market

On the basis of end-use, helicobacter pylori testing market is sectored into hospitals, clinics, diagnostic laboratories. In 2018, the diagnostic laboratories segment held a largest market share of the global market, by end users. The diagnostic laboratories segment is expected to be the fastest growing segments of market in 2018 owing to presence of well-established labs and increasing number of tests carried out in labs is expected to become the major factor for growth of the Helicobacter pylori testing industry.

Europe Helicobacter pylori testing market is set to proceed swiftly due to increasing adoption of advanced technologies

The H. pylori testing industry in Europe is still in its expanding phase and is expected to grow at a fast pace in the coming years. The easy availability of test kits and government support are few factors that are contributing towards revenue growth of market. Rising support of government for eradication of Helicobacter pylori will further aid in eliminating the risk of gastric cancer. Additionally, existence of notable business players, and strategic initiatives in region will contribute to growth of market. For instance, in October 2018, DiaSorin Inc., an Italian-based firm strategically collaborated with Meridian Bioscience, Inc. to sell DiaSorin’s Helicobacter pylori stool antigen test to detect infection on its automated LIAISON platform. Moreover, technology penetration is comparatively higher in the Europe that positively impacts the regional growth. Aforementioned factors coupled with enhanced regulatory scenario will foster the H. Pylori analysis market growth in Europe.

Market players majorly adopt collaboration strategies to sustain business competition

Escalating demand for adoption of advanced technologies coupled with rising number of firms offering innovative H. pylori testing solutions will augment market expansion. Few of the prominent players operating in Helicobacter pylori testing market are Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Quidel Corporation, Meridian Biosciences and Thermo Fisher. Market players are involved in various strategic alliances such as mergers & acquisitions, partnerships, and collaborations with other contributors to acquire significant revenue shares and competitive advantage over other market players. For instance, Diasorin S.P.A., in September 2017, purchased ELISA immunodiagnostic technology business from Siemens. The strategy aided in inclination of client towards the Clinical Laboratory Improvement Amendments (CLIA).

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X